U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683065) titled 'A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD' on June 12.
Brief Summary: This study aims to examine the retention rate of secukinumab in adult patients with plaque psoriasis (with or without psoriatic arthritis [PsA]) and metabolic dysfunction-associated steatotic liver disease (MASLD) in routine clinical practice in Spain, as well as hepatic biomarker trajectories. The study will use electronic medical record (EMR) data from multiple Spanish hospitals.
Study Start Date: July 15
Study Type: OBSERVATIONAL
Condition:
Plaque Psoriasis
Metabolic Dysfunction-Associated Steatotic Liver Disease
Recrui...